Physician profile
Robert Oliver
NPI 1891880928
$6,638.74
in general payments reported to CMS, 2019-2025
16 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $129 · 2021: $1,377 · 2022: $398 · 2023: $273 · 2024: $3,233 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,042 · Long Term Medical Supply Or Device Loan: $1,428 · Travel and Lodging: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,042.40 |
| Long Term Medical Supply Or Device Loan | $1,427.85 |
| Travel and Lodging | $1,155.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $2,715.82 | 2022-2025 | Integra, Durasorb Monofilament Mesh, Surgimend |
| Musculoskeletal Transplant Foundation INC. | $1,282.50 | 2024 | |
| Sientra, INC. | $661.59 | 2020-2022 | |
| Allergan, INC. | $661.35 | 2019-2022 | |
| Davol INC. | $525.00 | 2021 | |
| Tela Bio, INC. | $233.46 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Avita Medical Americas, LLC | $155.69 | 2025 | Cohealyx, Recell, Permeaderm |
| Pacira Pharmaceuticals Incorporated | $114.52 | 2024-2025 | Exparel |
| Motiva USA, LLC | $80.02 | 2024-2025 | |
| Medtronic, INC. | $50.00 | 2021 | |
| Abbvie INC. | $45.15 | 2025 | |
| Tei Biosciences INC | $42.55 | 2019 | |
| Galderma Laboratories, L.P. | $35.02 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $15.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.06 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $5.50 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.